Issue Date: May 28, 2007
India's Sun Buying Israel's Taro Pharma
Sun Pharmaceutical Industries, a generic drugs maker in India, has agreed to acquire Israel-based Taro Pharmaceutical Industries in a $454 million deal. Sun had sales of $555 million in its last fiscal year, compared with $298 million for Taro. Sun is active in the U.S. through its Caraco subsidiary, while North America represents more than 90% of Taro's sales.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society